Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt-Jakob disease

被引:32
作者
Vogelgesang, S
Glatzel, M
Walker, LC
Kroemer, HK
Aguzzi, A
Warzok, RW
机构
[1] Univ Greifswald, Dept Neuropathol, D-17487 Greifswald, Germany
[2] Univ Hamburg, Dept Neuropathol, Hamburg, Germany
[3] Emory Univ, Yerkes Reg Primate Res Ctr, Atlanta, GA 30322 USA
[4] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA
[5] Univ Greifswald, Dept Pharmacol, D-17487 Greifswald, Germany
[6] Univ Zurich, Dept Neuropathol, Zurich, Switzerland
关键词
Creutzfeldt-Jakob disease; cerebral amyloid angiopathy; P-glycoprotein; prion; proteopathies; beta-amyloid; Alzheimer's disease;
D O I
10.1007/s00401-006-0042-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The abnormal conformation and assembly of proteins in the central nervous system is increasingly thought to be a critical pathogenic mechanism in neurodegenerative disorders such as Creutzfeldt-Jakob disease (CJD) and Alzheimer's disease (AD). CJD is marked primarily by the buildup of misfolded prion protein (PrPSc) in brain, whereas the accrual of beta-amyloid protein (A beta) and tau protein are characteristic for AD. Prior studies have shown that the ATP-binding cassette transporter P-glycoprotein (P-gp) is a cellular efflux pump for A beta, and that age-associated deficits in P-gp may be involved in the pathogenesis of Alzheimer's disease. In the present study, we investigated the relationship between P-gp and idiopathic CJD, and found that CJD, like AD, is associated with a decrease in the expression of cerebrovascular P-gp. In some instances, A beta and PrP deposits coexist in cases of CJD, suggesting the possibility of pathogenic interactions. Since there is, to date, no evidence that PrP itself is a substrate for P-gp, we hypothesize that the age-related deficits in P-gp could promote the accumulation of PrPSc either by promoting the buildup of A beta (which could act as a seed for the aggregation of PrPSc), or by overloading the ubiquitin-proteasomal catabolic system, and thereby facilitating the accumulation of PrP. Alternatively, the loss of P-gp could be a non-specific response to neurodegenerative changes in the central nervous system. In either case, dysfunction of this critical toxin-elimination pathway in CJD and AD suggests that selectively increasing cerebrovascular P-gp function could open new therapeutic pathways for the prevention and/or treatment of a number of proteopathic disorders of the central nervous system.
引用
收藏
页码:436 / 443
页数:8
相关论文
共 53 条
[41]   The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis [J].
Smyth, MJ ;
Krasovskis, E ;
Sutton, VR ;
Johnstone, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (12) :7024-7029
[42]   Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux [J].
Tainton, KM ;
Smyth, MJ ;
Jackson, JT ;
Tanner, JE ;
Cerruti, L ;
Jane, SM ;
Darcy, PK ;
Johnstone, RW .
CELL DEATH AND DIFFERENTIATION, 2004, 11 (09) :1028-1037
[43]  
Terasaki Tetsuya, 2005, NeuroRx, V2, P63, DOI 10.1007/BF03206643
[44]   Pathogenesis of prion diseases [J].
Unterberger, U ;
Voigtländer, T ;
Budka, H .
ACTA NEUROPATHOLOGICA, 2005, 109 (01) :32-48
[45]   Deposition of Alzheimer's β-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans [J].
Vogelgesang, S ;
Cascorbi, I ;
Schroeder, E ;
Pahnke, J ;
Kroemer, HK ;
Siegmund, W ;
Kunert-Keil, C ;
Walker, LC ;
Warzok, RW .
PHARMACOGENETICS, 2002, 12 (07) :535-541
[46]   The Role of P-glycoprotein in Cerebral Amyloid Angiopathy; Implications for the Early Pathogenesis of Alzheimer's Disease [J].
Vogelgesang, Silke ;
Warzok, Rolf W. ;
Cascorbi, Ingolf ;
Kunert-Keil, Christiane ;
Schroeder, Eike ;
Kroemer, Heyo K. ;
Siegmund, Werner ;
Walker, Lary C. ;
Pahnke, Jens .
CURRENT ALZHEIMER RESEARCH, 2004, 1 (02) :121-125
[47]  
Walker Lary C, 2002, Curr Opin Investig Drugs, V3, P782
[48]   Apolipoprotein E4 promotes the early deposition of Aβ42 and then Aβ40 in the elderly [J].
Walker, LC ;
Pahnke, J ;
Madauss, M ;
Vogelgesang, S ;
Pahnke, A ;
Herbst, EW ;
Stausske, D ;
Walther, R ;
Kessler, C ;
Warzok, RW .
ACTA NEUROPATHOLOGICA, 2000, 100 (01) :36-42
[49]   The cerebral proteopathies - Neurodegenerative disorders of protein conformation and assembly [J].
Walker, LC ;
LeVine, H .
MOLECULAR NEUROBIOLOGY, 2000, 21 (1-2) :83-95
[50]   Apolipoprotein E4 promotes incipient Alzheimer pathology in the elderly [J].
Warzok, RW ;
Kessler, C ;
Apel, G ;
Schwarz, A ;
Egensperger, R ;
Schreiber, D ;
Herbst, EW ;
Wolf, E ;
Walther, R ;
Walker, LC .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1998, 12 (01) :33-39